A major global biopharmaceutical company faced inefficiencies with its clinical study data review process, relying on rigid tools that the clinicians found unhelpful. As a result, they shifted to using Excel spreadsheets and paper reports, leading to labor-intensive and slow data management practices. To address these challenges, the company implemented Revvity Signals Software, which offers enhanced interactive data visualization and analysis, improving the clinical data review process for clinicians and safety reviewers.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.clinicalleader.com/doc/revvity-signals-software-solution-for-clinical-study-data-review-used-across-all-therapeutic-areas-and-all-phases-of-clinical-trials-0001
